Exchange: OTC·Updated 11:53 AM EDT

SCPXScorpius Holdings Inc.

$0.0056
$0.0044
(366.67%)
Today
Reported EarningsApr 30
Mkt Cap$342,399.00
Vol3.00

About

Scorpius Holdings, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company's T-cell activating platform (TCAP) produces therapies designed to turn immunologically cold tumors to hot and be administered in combination with checkpoint inhibitors and other immuno-modulators to increase clinical effectiveness. Its TCAP product candidates from the company's ImPACT and ComPACT platforms are produced from allogeneic cell lines expressing tumor-specific proteins common among cancers. The company was founded by Jeffrey Alan Wolf on June 10, 2008 and is headquartered in San Antonio, TX.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Scorpius Holdings Inc.?
What is the 52-week high for Scorpius Holdings Inc.?
What is the 52-week low for Scorpius Holdings Inc.?
What is Scorpius Holdings Inc. stock price today?
What was Scorpius Holdings Inc. stock price yesterday?
What is the Price-to-Book ratio of Scorpius Holdings Inc.?
What is the 50-day moving average of Scorpius Holdings Inc.?

Latest SCPX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.